Click here to view full press release
9-11 First Responder Vincent Caprio to be Featured on Close Up Radio

EASTON, CT, UNITED STATES, September 4, 2024 /EINPresswire.com/ — The official number is 2,977. This is how many people passed on from the attack on the World Trade Center on September 11, 2001. Over 7,000 9/11 first responders and 9/11survivors combined have passed away since 9/11 from their 9/11-related injuries. Twenty-three years later, many 9/11 first responders and 9/11 survivors, like Vincent Caprio, Executive Director of NanoBCA, are being diagnosed with illnesses such as cancer and respiratory disease every day. Many people like Vincent were not diagnosed with health issues until 15-20 years after 9/11.

“At present time, the 9/11 World Trade Center Health Program was set up to provide medical monitoring and treatment of WTC-related health conditions. Today, there are 110,000 people enrolled in the program. Each 9/11 first responder and 9/11 survivor’s medical conditions have to be certified by the National Institute for Occupational Safety and Health (NIOSH). Once a person’s medical condition has been certified, then they are able to apply for compensation from the Victim’s Compensation Fund. It is a very complex process, requiring hundreds of hours in order to get certified and receive compensation. While legal guidance is provided, the medical certification process must be done yourself.,” explains Vincent.

These Americans were not policemen, firemen, or EMTs. “They were volunteers, like me, who didn’t have that hierarchy to lean on,” explains Vincent. “On the day of the attack I remained at Ground Zero for 22 hours. I then volunteered for over 400 hours in the months following 9/11. I spent seven years getting into the 9/11 WTC Health Program,” shares Vincent. “And that’s after being decorated by Congress and receiving a certificate from the State of Connecticut stating, ‘Vincent Caprio, in recognition of your heroic dedication to your fellow citizens as a survivor and a 9/11 first responder during the attack on the Twin Towers.’”

The program is a lifesaver for those who are accepted. “Once you’re in, it’s wonderful. I’ve been diagnosed with thyroid cancer, GERD and have chronic respiratory disease. The program pays for my pulmonary doctor and endocrinologist. It covers my medication and inhaler. It’s a godsend. But no one should have to fight for seven years to get certified,” laments Vincent.

As a member of Voices Center for Resilience, Vincent meets with other 9/11 first responders and 9/11 survivors remotely to help them deal with grief and offer hope. As an organization, Voices offers long-term support and resources for mental health care and wellness to victims’ families, responders, survivors, and families of those who died from 9/11-related illnesses “My experience with Voices made me acutely aware that 9/11 first responders and 9/11 survivors, who suffer from PTSD, need mental health therapy regularly. Our government needs to support everyone who responded to the 9/11 disaster to ensure that Americans feel safe responding to overwhelming disasters in the future,” Vincent explains.

Voices Center for Resilience has been sponsoring an annual conference at Ground Zero since 2003. “As every year, this year I will be at the conference along with all the people that manage the Victims Compensation Fund and the 9-11 WTC Health Program. We will be meeting with family members, first responders, and survivors. Our 9/11 community will be there.”

Close Up Radio will feature Vincent Caprio in an interview with Doug Llewelyn on Friday, September 6th at 11 am EST

Listen to the show on BlogTalkRadio

If you have any questions for our guest, please call (347) 996-3389

For more information about Vincent Caprio, please visit the following websites
https://eastoncourier.news/2024/03/03/easton-9-11-responder-honored-with-state-citation/
https://voicescenter.org/
https://nanobca.org/
http://vincentcaprio.org/

Lou Ceparano
Close Up Television & Radio
+1 631-850-3314
email us here
Visit us on social media:
Facebook

AGENDA

2:00-2:05  Opening Remarks
Vincent Caprio
Executive Director, NanoBusiness Commercialization Association (NanoBCA)
vincentcaprio@nynanobusiness.org

Emerging Technologies 2024
Wednesday, October 9, 2024

Location
Pillsbury Winthrop Shaw Pittman LLP
1200 Seventeenth Street NW
Washington, DC 20036-3006

2:05-2:15 Trifluoroacetic Acid in the Environment: Consensus, Gaps, and Next Steps
Society of Environmental Toxicology and Chemistry

Governor Healey signs new law to ban PFAS in firefighter protective gear
MASSPIRG

Some school uniforms found to have high levels of PFAS chemicals, new study says
Fox5 DC

Sam Brauer, PhD
Founder & Principal, Nanotech Plus
2021 NanoBCA Lifetime Achievement Award Recipient
sbrauer@nano-biz.com

————————————————————
2:15-2:30  EHS Update
Carla N. Hutton
Regulatory Analyst, Bergeson & Campbell, P.C.
chutton@lawbc.com

NASEM Will Hold Virtual Town Hall on September 5 as Part of Its Quadrennial Review of the NNI

EPA Proposes SNUR for Graphene Nanoplatelets (Generic)

NSF Biomaterials Program Publishes RFI

EPA Authors Describe Categorization Approach to PFAS to Identify Potential Candidates for Testing and Human Health Assessments

————————————————————
2:30-2:45 Education Update
Marco Curreli, PhD
Executive Director, Omni Nano
marcocurreli@omninano.org

————————————————————
2:45-2:50 Q&A

————————————————————
2:50  Conclusion

AGENDA

2:00-2:10  Opening Remarks
Vincent Caprio
Executive Director, NanoBusiness Commercialization Association (NanoBCA)
vincentcaprio@nynanobusiness.org

United States National Debt $35T

Article Analysis
Sam Brauer, PhD
Founder & Principal, Nanotech Plus
2021 NanoBCA Lifetime Achievement Award Recipient
sbrauer@nano-biz.com

“Everyone is drinking it”: Why this type of ”forever chemical” seems to be everywhere
Scientists are beginning to focus on new types of “forever chemicals” that are far more widespread than earlier realized.
The Washington Post

————————————————————
2:10-2:30  EHS Update
Lynn L. Bergeson
Managing Director, Bergeson & Campbell, P.C.
NanoBCA EHS Chair
lbergeson@lawbc.com

Lynn L Bergeson, Kelly N Garson, “Loper Bright and TSCA: Will the demise of Chevron matter?,” Chemical Watch, July 22, 2024.

Senate Committee Will Hold Hearing on Understanding the Potential Environmental Impacts of 6PPD

EPA Announces Changes to When It Assesses Potential Exposure to Pesticide Spray Drift

BETO Announces Awards to 13 Small Businesses to Develop Innovative Biobased Products and Biomass Processing Technologies

————————————————————
2:30-2:45 Wall Street Update – First half 2024
Scott Livingston
CEO, Livingston Securities
scott@livingstonsecurities.com

————————————————————
2:45-2:50 Q&A

————————————————————
2:50  Conclusion

————————————————————
Our monthly webinars address topics involving the relationship between the science of nanotechnology and Environmental, Health & Safety (EHS), US Legislation, Education, Finance, Manufacturing and Foreign Policy. One of the benefits of NanoBCA membership is access to our previous webinars with America’s leading scientists and engineers.

INDIVIDUAL MEMBERSHIP $250

ACADEMIC/YOUNG PROFESSIONAL MEMBERSHIP $100

The NanoBusiness Commercialization Association (NanoBCA) highly recommends the following event:

Responsible Development, Social Science, and the National Nanotechnology Initiative: A Workshop to Explore Past and Future Intersections
Wednesday, July 24, 2024
9:00am – 5:00pm

Since its inception, the National Nanotechnology Initiative (NNI) has emphasized the importance of responsible development, and social scientists have played important roles in the interdisciplinary research that supports fundamental and applied research in nanotechnology. Following this tradition, the NNI and the National Nanotechnology Coordination Office (NNCO) are convening a workshop to bring together federal experts in nanotechnology with social scientists with expertise on specific tools and frameworks relevant to the responsible development of emerging technologies. The agenda will include a presentation about the recently released “Blueprint for the Use of Social and Behavioral Science to Advance Evidence-Based Policymaking,” introductions to key nanotechnology case studies by federal experts, and flash talks by social scientists. The meeting will promote brainstorming new intersections between social science and nanotechnology R&D with the goals of i) integrating social science into future visions of interdisciplinary research, development, and training, and ii) reinvigorating networks that connect the NNI to the social science community.

———————————————-
Meeting Location:

470 L’Enfant Plaza SW, Suite 8001, Washington, DC 20024. Directions are available here.

Virtual participation is also available, but online attendees will not be able to contribute to small group discussions in the afternoon session. Questions may be collected from online participants to inform the meeting.

———————————————-
Register today to listen in on this important exchange:

CLICK HERE FOR IN-PERSON REGISTRATION

CLICK-HERE FOR VIRTUAL REGISTRATION

———————————————-
AGENDA

9:00am  Welcome and introductions

9:30am  Presentation and Q&A on the “Blueprint for the Use of Social and Behavioral Science to Advance Evidence-Based Policymaking”

9:55am  Presentation and Q&A on the ELSI section of the National Nanotechnology Initiative Environmental, Health, and Safety Research Strategy: 2024 Update

10:15am  Break

10:30am  Social Science Flash Talks (10 mins each)

12:00pm  Lunch

12:45pm  Social Science Flash Talks (10 mins each)

1:30pm  Nanotechnology Case Studies – Introductions by NSET agency representatives

2:15pm  Break

2:30pm  Small-group discussions (rotating among case studies) [Note: this portion of the agenda unavailable to online participants]

4:30pm  Report Out and Discussion

4:45pm  Closing and Next Steps

———————————————-
CONFIRMED PARTICIPANTS

Briñas, Raymond FDA, Office of Food Additive Safety

Brough, Branden NNCO, Director

Chen, Kaiping University of Wisconsin – Madison; Communication Strategies with Diverse Groups

Chen, Hongda USDA/NIFA

Chen, Jermont NIH/NBIB, Division of Discovery Science and Technology

Daemmrich, Arthur Consortium for Science, Policy and Outcomes; Chemical Risk, Testing and Regulatory Cultures

Delborne, Jason NNCO, AAAS Science & Technology Policy Fellow

Evans, Sam Weiss National Security Commission on Emerging Biotechnology; Emerging Technologies and Security

Grieger, Khara North Carolina State University; Risk Analysis, Stakeholder Engagement

Haes, Amanda DOE/Basic Energy Sciences

Hartley, Sarah University of Exeter (UK); Risk Assessment, Responsible Innovation

Merid, Beza Arizona State University; Digital Health and Racial Justice

Nelson, John P. Georgia Institute of Technology; Public Value Mapping, Ethics of Emerging Tech

Palmer, Megan Gingko Bioworks; iGEM Policy and Practice Program

Spadola, Quinn NNCO, Deputy Director

Shelley-Egan, Clare Delft University of Technology; Responsible Development and Nanotechnology

Tomblin, David University of Maryland; Participatory Technology Assessment

Udu-gama, Natasha American Geophysical Union – Thriving Earth Exchange; Community Science

Vietas, Jay NIOSH/Nanotechnology Research Center

Zhernenkov, Misha DOE/Basic Energy Sciences

———————————————-
For further information, contact:

Jason Delborne, AAAS Science and Technology Policy Fellow, NNCO

———————————————-
We hope you will be able to participate!

The NanoBusiness Commercialization Association (NanoBCA) would like to congratulate the recipients of the 2024 Kavli Prize in Nanoscience: Robert S. Langer, Armand Paul Alivisatos, and Chad A. Mirkin. I have had the honor of meeting all three of these distinguished scientists from our Nanotechnology Community.

The 2024 Kavli Prize Laureates in the fields of astrophysics, nanoscience and neuroscience were announced this week by the Kavli Foundation. The Kavli Prize in Nanoscience was awarded to Langer, Alivisatos, and Mirkin “for pioneering work integrating synthetic nanoscale materials with biological function for biomedical applications.” You can watch a 20-minute video of the Kavli Prize announcement here.

The 2024 Kavli Prize in Nanoscience honors Robert S. Langer, Armand Paul Alivisatos and Chad A. Mirkin who each revolutionized the field of nanomedicine by demonstrating how engineering nanoscale materials can advance biomedical research and application. Their discoveries contributed foundationally to the development of therapeutics, vaccines, bioimaging and diagnostics.

“The three scientists, Langer, Alivisatos and Mirkin, have broadened the scientific field of nanoscience, building from fundamental research. By scientific curiosity they have become inventors for the future of nanoscience and biomedicine,” stated Bodil Holst, Chair of the Nanoscience Committee.

Robert S. Langer was the first to develop nano-engineered materials that enabled the controlled release, or regular flow, of drug molecules. This capability has had an immense impact for the treatment of a range of diseases, such as aggressive brain cancer, prostate cancer and schizophrenia. His work also showed that tiny particles, containing protein antigens, can be used in vaccination, and was instrumental in the development of the delivery of mRNA vaccines.

Armand Paul Alivisatos demonstrated that semiconductor nanocrystals, or quantum dots (nanoparticles that possess bright, size-dependent light-emitting properties), can be used as multicolor probes in bioimaging. Essential to this achievement was the synthesis of biocompatible nanocrystals. Semiconductor nanocrystals became the basis for the widely used research and diagnostic tools such as live cell tracking, labelling and in vivo imaging.

Chad A. Mirkin engineered spherical nucleic acids (SNA) using a gold nanoparticle as the core, and a cloud of radially distributed DNA or RNA strands as the shell. He was then able to show how SNAs can be combined to create larger structures and how they can be used in biodiagnostics. His discovery led to the development of fast, automated point-of-care medical diagnostic systems.

Once again, we would like to congratulate Robert S. Langer, Armand Paul Alivisatos, and Chad A. Mirkin for their enormous contributions to our Nanotechnology Community.

The NanoBusiness Commercialization Association (NanoBCA) highly recommends the following event:

TSCA Reform – Eight Years Later
Wednesday, June 26, 2024
8:00am-4:30pm
Hybrid (in-person in DC & via livestream)

Lynn L. Bergeson Managing Director of Bergeson & Campbell, P.C. and NanoBCA EHS Chair will be speaking at 3:PM ET on the panel Shaping the Agenda: Section 21 Citizens’ Petitions and Other Mechanisms Influencing Priority Setting

All times noted are EASTERN Time. The event will begin at 8:00 AM Eastern, 7 AM Central, 6 AM Mountain, and 5 AM Pacific.

This event is free and open to the public but you must register.

• In-person attendance will be located at The George Washington University Milken Institute School of Public Health (map)
  • If you wish to attend the full conference, you will need to register for BOTH the morning sessions AND the afternoon sessions.
  • REGISTER to attend the MORNING SESSIONS in DC
  • REGISTER to attend the AFTERNOON SESSIONS in DC
  • Seating is limited. Registration will close on June 21 OR when capacity is reached.
  • Anyone who attends in person is welcome to enjoy a complimentary grab-and-go lunch (12:15 PM – 1:30 PM). However, we will not be able to accommodate dietary restrictions.
• Virtual attendance will be via YouTube livestream.
  • REGISTER to attend VIRTUALLY
  • Livestream link will be emailed upon registration.
  • Registration will close on June 25.

Free Introductory TSCA Course

• Please fill out this form if you would like complimentary access to Bergeson & Campbell, P.C.’s “An Overview of TSCA” online, on-demand video course.

Continuing Legal Education (CLE)

• CLE credit will be offered in Vermont and Pennsylvania for in-person participants only. ELI is not able to offer CLE credit for virtual participants.
• 5.5 hours of general CLE credit total (morning sessions: 3.0 hours; afternoon sessions: 2.5 hours).

Questions?

• For issues registering, or to cancel/change your registration, contact events@eli.org.
• For substantive questions, contact Madison Calhoun (calhoun@eli.org).

 —————————————
An ELI, Bergeson & Campbell, P.C., and the George Washington University Milken Institute School of Public Health Co-Sponsored Annual Conference

This conference marks the eighth Toxic Substances Control Act Annual Conference, expanding upon TSCA Reform – Seven Years Later, TSCA Reform – Six Years Later, TSCA Reform – Five Years Later, TSCA Reform – Four Years Later, TSCA: Three Years Later, TSCA Reform at 2 Years and TSCA Reform: One Year Later. Leading panelists will reflect on the challenges and accomplishments since the implementation of the 2016 Lautenberg Amendments and where the Toxic Substances Control Act (TSCA) stands today.

Panelists will dive into key hot topics, including chemical prioritization and risk evaluation, risk management, new chemical review, Section 21 petitions and other TSCA provisions available to third parties, and much more. Join ELI, Bergeson & Campbell, P.C., the George Washington University Milken Institute School of Public Health, leading experts, and distinguished speakers for a robust exploration of the issues and regulations surrounding TSCA.

—————————————
AGENDA

8:00 AM – 8:05 AM  Welcome
Madison Calhoun, Senior Manager, Educational Programs, Environmental Law Institute

8:05 AM – 9:00 AM  Hot Topics Panel

TSCA Administrative and Judicial Litigation: Much Going On!

TSCA is the subject of significant administrative and judicial litigation. Inhance Technologies raises serious implications for the U.S. Environmental Protection Agency (EPA)’s regulation of significant new uses under TSCA Section 5. TSCA Section 4 orders are being litigated, the final Section 6 risk management rule for asbestos is being challenged, as are other aspects of EPA’s implementation of Lautenberg. This panel will feature a spirited discussion of these disputes and the implications of their resolution.

Mark N. Duvall, Principal, Beveridge & Diamond, P.C. Moderator
Eric P. Gotting, Partner, Keller and Heckman, LLP
Adam M. Kushner, Partner, Hogan Lovells US LLP
Tosh Sagar, Senior Attorney, Earthjustice
Robert M. Sussman, Principal, Sussman & Associates

9:00 AM – 9:30 AM  Keynote Address
Michal Ilana Freedhoff, Ph.D., Assistant Administrator, Office of Chemical Safety and Pollution Prevention, U.S. Environmental Protection Agency

9:30 AM – 10:45 AM  Panel 1: Risk Management

EPA’s issuance of its first-ever risk management rule is a significant achievement and offers important insights into how EPA defines the “extent necessary” to control unreasonable risks, under what circumstances EPA will not seek to ban a chemical use, what issues are likely to be litigated, and much more. This panel will discuss the risk management rule and its implications.

Karyn M. Schmidt, Senior Director, Regulatory & Scientific Affairs, American Chemistry Council, Moderator
MaryAnn Hoff, Global Director Advocacy, EHS & Product Stewardship, PPG
Jonathan Kalmuss-Katz, Supervising Senior Attorney, Earthjustice
Eileen Murphy, Ph.D., Director, Existing Chemicals Risk Management Division, U.S. Environmental Protection Agency

10:45 AM – 11:00 AM  Break

11:00 AM – 12:15 PM  Panel 2: Risk Evaluation and the Supporting Role Sections 4 and 8 Play

EPA has been busy refining its chemical prioritization and risk evaluation processes to ensure its decisions are informed by available data and new data are generated under Section 4. This panel will consider these revised processes; the role and extent of peer review; the utility and timing of Section 4 test rules; the disposition of chemicals remaining on the 2014 Work Plan Chemicals list; and much more.

Maria J. Doa, Ph.D., Senior Director, Chemicals Policy, Environmental Defense Fund, Moderator
David B. Fischer, Counsel, Keller and Heckman LLP
Jeffery T. Morris, Ph.D., Director, Existing Chemicals Risk Assessment Division, Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency
Katherine O’Brien, Senior Attorney, Toxic Exposure and Health Program, Earthjustice
Judah Prero, Counsel, Arnold & Porter
Tracey Woodruff, Ph.D., Professor and Director, University of California, San Francisco Program on Reproductive Health and the Environment

12:15 PM – 1:30 PM  Luncheon Break

Anyone who attends in person is welcome to enjoy a complimentary grab-and-go lunch. However, we will not be able to accommodate dietary restrictions.

1:30 PM – 2:45 PM  Panel 3: New Chemical Review

EPA continues to revise its new chemical review process. This panel will discuss the latest updates, whether challenges are being addressed and how, whether review times are being diminished, and much more.

Samantha Liskow, Lead Counsel, Health Program, Environmental Defense Fund, Moderator
Shari Barash, Director, New Chemicals Division, Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency
Kyla Bennett, Ph.D., Director, Public Employees for Environmental Responsibility
Kerry Coy, Product Regulation Specialist, BASF Corporation (virtual)
Richard E. Engler, Ph.D., Director of Chemistry, Bergeson & Campbell, P.C.
Daniel Rosenberg, Senior Attorney, Environmental Health, Natural Resources Defense Council

2:45 PM – 3:00 PM  Break

3:00 PM – 4:15 PM  Panel 4: Shaping the Agenda: Section 21 Citizens’ Petitions and Other Mechanisms Influencing Priority Setting

Citizens’ petitions under TSCA Section 21 are increasingly playing a prominent role in influencing EPA’s policy and regulatory priorities. Other mechanisms are also being used to revisit EPA’s priorities. This panel will discuss the utility of these mechanisms, how they are impacting EPA’s regulatory agenda, and other opportunities for citizen engagement.

Lynn L. Bergeson, Managing Partner, Bergeson & Campbell, P.C., Moderator
Ryan J. Carra, Ph.D., Principal, Beveridge & Diamond, P.C.
Michael Connett, Partner, Siri & Glimstad
Thomas Groeneveld, Senior Advisor, Existing Chemicals Risk Management Division, U.S. Environmental Protection Agency
Robert M. Sussman, Principal, Sussman & Associates

4:15 PM – 4:30 PM  Concluding Remarks and Adjournment
Jordan Diamond, President, Environmental Law Institute

—————————————
We would like to thank Lynn L. Bergeson for her continued dedication and contributions to the nanotechnology community.

Please join us on June 26^th for this important event.

NanoBCA Webinar
Wednesday, May 29, 2024
2:00-3:00PM

————————————————————
AGENDA

2:00-2:10  Opening Remarks
Vincent Caprio
Executive Director, NanoBusiness Commercialization Association (NanoBCA)
vincentcaprio@nynanobusiness.org

Nano drug accelerates diabetic wound healing in mice
SCIENMAG

Air Force unveils photos of newest stealth bomber
New York Post

Influencers Are Saying Sunscreen Causes Cancer. They Are Wrong.
The Wall Street Journal

How 3M discovered — and hid — the dangers of forever chemicals
The New Yorker

————————————————————
2:10-2:30  EHS Update
Lynn L. Bergeson
Managing Director, Bergeson & Campbell, P.C.
NanoBCA EHS Chair
lbergeson@lawbc.com

TSCA Reform – Eight Years Later
June 26, 2024
8:00am-4:30pm ET
Lynn will be speaking at 3:00pm

Maine Amends Its PFAS Statute, Exempting Certain Product Categories from the Sales Prohibition and Eliminating the General Notification Requirement

Nano and Other Emerging Chemical Technologies Blog

————————————————————
2:30-2:50 Cybersecurity workshop stresses the importance of online safety
Ken Russell, PhD
Chief Information and Innovation Officer, Author
drkenrussell@gmail.com

————————————————————
2:50-3:00 Q&A

————————————————————
3:00  Conclusion

Our good friend, Alan Hinchman, and Chief Revenue Officer of GrayMatter Systems, has shared with us some very good news!

GrayMatter Partners with Tailwind Capital to Transform Industrial Intelligence
May 2, 2024

Pittsburgh, PA – GrayMatter, a top Industrial Intelligence technology solution provider, is accelerating its expansion with a significant investment from Tailwind Capital, a private equity firm focused on investments in growth-oriented, middle-market services companies.

This partnership comes at a pivotal time for GrayMatter. The company recently celebrated another year in which it met its organic growth objectives and completed two successful acquisitions. Over the past seven years, GrayMatter has successfully completed five strategic acquisitions, invested in a new operations team in India and assembled a respected team of technical engineers.

“Our industry is at an inflection point, and with Tailwind’s investment, we have the opportunity to create a new brand of Industrial Intelligence. Our industrial automation, MES, analytics and cyber for OT offerings are in high demand. This investment will allow us to invest deeper in our platform and people to ensure we have the full suite of solutions and offerings for our long-standing and loyal customers,” said James Gillespie, CEO and co-founder of GrayMatter. “We look forward to further empowering operators by providing them with leading automation and Industrial Intelligence solutions.”

Tailwind Capital has a long history of partnering with management teams to drive transformative growth by utilizing its Accelerate Change playbook, which is predicated on investments in talent, technology and transformative M&A. The firm has proven expertise investing in highly technical engineering services businesses and has worked closely with Paul Galeski to develop a thesis in the industrial automation and intelligence market. Galeski founded MAVERICK Technologies, which he successfully sold to Rockwell Automation before becoming the Vice President & GM, Global Solutions and Services. He will serve as the Executive Chairman of GrayMatter.

“We are thrilled to partner with Jim, Paul and the entire extended GrayMatter team. The company has a well-earned reputation as a leading provider of automation and Industrial Intelligence services. We look forward to further supporting their strategic objectives and helping them accelerate their growth, both organically and via acquisitions,” said Andrew Mayer, a Partner at Tailwind Capital.

“We are excited to have Tailwind join us as we push the boundaries of what’s possible in Industrial Intelligence,” Gillespie said. “The firm has a long track record of working closely with services businesses to accelerate growth. Additionally, Paul brings a wealth of experience in industrial automation, and we look forward to partnering on strategic initiatives that will allow us to better serve our customers and drive value for all stakeholders.”

“Jim and the GrayMatter team have built a wonderful business,” said Galeski. “They solve complex problems and deliver high-ROI solutions for their customers. I am thrilled to have the opportunity to work with Jim and Tailwind to further scale GrayMatter into the market-leading provider of industrial automation and intelligence solutions.”

——————————————–
Congratulations to Alan Hinchman and the GrayMatter team on the successful partnership!